BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37882730)

  • 1. Cannabinoid treatments in epilepsy and seizure disorders.
    Devinsky O; Jones NA; Cunningham MO; Jayasekera BAP; Devore S; Whalley BJ
    Physiol Rev; 2024 Apr; 104(2):591-649. PubMed ID: 37882730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
    Rosenberg EC; Patra PH; Whalley BJ
    Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
    Devinsky O; Cilio MR; Cross H; Fernandez-Ruiz J; French J; Hill C; Katz R; Di Marzo V; Jutras-Aswad D; Notcutt WG; Martinez-Orgado J; Robson PJ; Rohrback BG; Thiele E; Whalley B; Friedman D
    Epilepsia; 2014 Jun; 55(6):791-802. PubMed ID: 24854329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Source of cannabinoids: what is available, what is used, and where does it come from?
    Specchio N; Pietrafusa N; Cross HJ
    Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy.
    Yao I; Stein ES; Maggio N
    Pharmacol Ther; 2019 Oct; 202():32-39. PubMed ID: 31176695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids and Epilepsy.
    Rosenberg EC; Tsien RW; Whalley BJ; Devinsky O
    Neurotherapeutics; 2015 Oct; 12(4):747-68. PubMed ID: 26282273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.
    Zavala-Tecuapetla C; Luna-Munguia H; López-Meraz ML; Cuellar-Herrera M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Cannabidiol Safety: A Review.
    Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
    Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid therapy in epilepsy.
    Billakota S; Devinsky O; Marsh E
    Curr Opin Neurol; 2019 Apr; 32(2):220-226. PubMed ID: 30676535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids in epilepsy: clinical efficacy and pharmacological considerations.
    Espinosa-Jovel C
    Neurologia (Engl Ed); 2023; 38(1):47-53. PubMed ID: 34824031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Cannabis to Cannabidiol to Treat Epilepsy, Where Are We?
    Lippiello P; Balestrini S; Leo A; Coppola A; Citraro R; Elia M; Russo E; De Sarro G
    Curr Pharm Des; 2016; 22(42):6426-6433. PubMed ID: 27587196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
    Tambe SM; Mali S; Amin PD; Oliveira M
    J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the role of cannabinoids on osteoporosis: a review.
    Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
    Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures.
    Mascal M; Hafezi N; Wang D; Hu Y; Serra G; Dallas ML; Spencer JPE
    Sci Rep; 2019 May; 9(1):7778. PubMed ID: 31123271
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Canseco-Alba A; Rodríguez-Manzo G
    Rev Invest Clin; 2023; 75(3):105-128. PubMed ID: 37441766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.